Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Nuclear transfer cloning and the United Nations

Article Abstract:

Issues related to the proposal of a global ban on all the forms of human nuclear clone transfer and the stands taken by the United Nations in implementing it are presented. The ban on reproductive human cloning could be considered as a humanitarian measure, however, at the same time the manner in which the ban is sought should be considered carefully in order to avoid problems in the future.

Author: Perry, Anthony CF
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Political aspects, Embryology, Experimental, Embryological research, Human cloning

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Death in gene therapy trial raises questions about private IRBs

Article Abstract:

The death of a patient undergoing gene therapy trial testing a rheumatoid arthritis treatment has raised questions about the institutional review boards (IRBs). The U.S. Food and Drug Administration (FDA) declares that IRBs, whether for-profit or traditional, are required to follow FDA regulations.

Author: Ledford, Heidi
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
Drugs, Care and treatment, Patient outcomes, Clinical trials, Biological products industry, Rheumatoid arthritis, Gene therapy, United States. Food and Drug Administration, Targeted Genetics Corp., TGEN

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Merck's HIV vaccine flop brings vectors under closer scrutiny

Article Abstract:

The benefits and limitations of the use of disabled cold virus as a vector in vaccines targeted against HIV are presented. The safety of the use of certain vectors in vaccines has become a concern after the failure of Merck's V520 HIV vaccine.

Author: Ledford, Heidi
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2008
Pharmaceutical preparations, Pharmaceutical industry, Complications and side effects, AIDS vaccines, Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Laws, regulations and rules, Government regulation, United States, Company legal issue, Investigations
Similar abstracts:
  • Abstracts: Conference calls and information asymmetry. Use of r2 in accounting research: measuring changes in value relevance over the last four decades
  • Abstracts: Agency costs and the performance implications of international joint venture internalization. An empirical test of heuristics and biases affecting real option valuation
  • Abstracts: Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways
  • Abstracts: IT brass: C4 reform huge, but moving in 'right direction'. U.S. needs new ways to understand enemy use of space: But funding not a priority
  • Abstracts: The utility of the relationship metaphor in consumer markets: a critical evaluation. Pedagogy and relationship marketing: opportunities for frame restructuring using African drumming
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.